You are here: Industry Insights > acquisition

News List

Cryoport to Acquire CRYOPDP contractpharma
August 24, 2020
Expands Cryoport’s global supply chain network and services with more than 220 employees located in 22 global facilities in 12 countries.
Sanofi to acquire Principa Biopharma for $3.68 billion europeanpharmaceuticalreview
August 21, 2020
Sanofi is set to acquire Principia Biopharma Inc. for a total aggregate equity value of $3.68 billion, at $100 per share.
Ligand to Acquire Pfenex americanpharmaceuticalreview
August 19, 2020
Ligand Pharmaceuticals and Pfenex announced the signing of a definitive agreement for Ligand to acquire all outstanding shares of Pfenex for $12.00 per share in cash or $438 million in equity value on a fully diluted basis.
Biological E. acquires Akorn India expresspharma
August 18, 2020
The timing of this acquisition is fortuitous as it will immediately allow us to expand our capacity to manufacture our investigational COVID-19 vaccine, said the company.
Bayer to acquire KaNDy Therapeutics with $425 million upfront payment europeanpharmaceuticalreview
August 17, 2020
Bayer will acquire KaNDy Therapeutics Ltd for an upfront cost of $425 million to expand its drug development pipeline in women’s healthcare.
Ligand Pharmaceuticals agrees to acquire Pfenex for $516m pharmaceutical-technology
August 12, 2020
Ligand Pharmaceuticals has entered into a definitive agreement to acquire development and licencing biotechnology firm Pfenex in a deal valued at approximately $516m.
Rafarma to be Acquired by R. & D. Biocogency Laboratories americanpharmaceuticalreview
August 07, 2020
Rafarma Pharmaceuticals has reached an agreement to be acquired by R. & D. Biocogency Laboratories. Under the agreed terms, Bio-cogency will acquire majority control of Rafarma Pharmaceuticals upon completion of Biocogency’s transition to GAAP ...
Sun Pharma arm to acquire Aquinox Pharmaceuticals (Canada) expresspharma
July 30, 2020
The cost of acquisition is about $8.2 million.
Gilead to acquire stake in Tizona Therapeutics for $300n pharmaceutical-technology
July 23, 2020
Gilead Sciences is set to acquire a 49.9% equity interest in cancer immunotherapies maker Tizona Therapeutics through an investment of $300m.
Nexelis Acquires AIT Bioscience contractpharma
July 23, 2020
AIT Bioscience’s advanced testing capacity bolsters service offering in the bioanalytical segment.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page